Reference:
RT00260
The present invention relates to N-(3-(5-(pyrimidin-4-yl)thiazol-4-yl)phenylsulfonamide compounds […]
Inventors have surprisingly found that Emricasan is a much more potent inhibitor of monocyte […]
The present invention relates to the treatment of acidosis related diseases. In this study, the […]
Heart failure with preserved ejection fraction (HFpEF) which results from diastolic dysfunction is a […]
The present invention relates to a method for promoting wound healing in a subject suffering from […]
The present invention relates to the treatment of idiopathic pulmonary fibrosis. Today, there is no […]
Despite reaching an epidemic status worldwide, metabolic disorders, notably diabetes, still miss […]
The invention relates to new bis-triazole 2,4,6-triarylpyridines compounds and their use in the […]
Chronic wounds and in particular diabetic ulcers are a serious complication of diabetes. Unresolved […]
The present invention relates to methods for enhancing the potency of the immune checkpoint […]
Research tool licensing team
researchtools@inserm-transfert.fr
User accounts are momentarily unavailable
The Inserm Transfert website is currently undergoing maintenance. It will be available again in a few hours.